Biomarkers of hypochromia: The contemporary assessment of iron status and erythropoiesis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Urrechaga, Eloísa ^a   Borque, Luís ^b   Escanero, Jesús F ^b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER; IRON;

BLOOD ANALYSIS; BLOOD SAMPLING; BONE MARROW CELL; CHRONIC KIDNEY DISEASE; EARLY DIAGNOSIS; ERYTHROCYTE DISORDER; ERYTHROID CELL; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HYPOCHROMISM; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; LABORATORY TEST; RETICULOCYTE; REVIEW; THALASSEMIA; TRANSFERRIN BLOOD LEVEL; BLOOD; ERYTHROCYTE; METABOLISM; PATHOLOGY;

ANEMIA, HYPOCHROMIC; BIOLOGICAL MARKERS; ERYTHROCYTES; ERYTHROPOIESIS; FERRITINS; HUMANS; IRON; RETICULOCYTES; TRANSFERRIN;

EID: 84875538990     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/603786     Document Type: Review

References (67)

1. Swinkels D. W., Janssen M. C. H., Bergmans J., Marx J. J. M., Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clinical Chemistry 2006 52 6 950 968 2-s2.0-33646899011 10.1373/clinchem.2006.068684 (Pubitemid 43794403)
2. Ganz T., Nemeth E., Iron sequestration and anemia of inflammation. Seminars in Hematology 2009 46 4 387 393 2-s2.0-70349325941 10.1053/j. seminhematol.2009.06.001
3. Fleming R. E., Bacon B. R., Orchestration of iron homeostasis. The New England Journal of Medicine 2005 352 17 1741 1744 2-s2.0-17644363328 10.1056/NEJMp048363 (Pubitemid 40570920)
4. Weiss G., Goodnough L. T., Anemia of chronic disease. The New England Journal of Medicine 2005 352 10 1011 1023 2-s2.0-14744278436 10.1056/NEJMra041809 (Pubitemid 40349504)
5. Goodnough L. T., Skikne B., Brugnara C., Erythropoietin, iron, and erythropoiesis. Blood 2000 96 3 823 833 2-s2.0-0034254356 (Pubitemid 30616842)
6. Mast A., The clinical utility of peripheral blood tests in the diagnosis of iron deficiency anemia. Bloodline 2001 1 7 9
7. Coyne D., Iron indices: what do they really mean? Kidney International Supplements 2006 101 S4 S8 2-s2.0-33746568510 (Pubitemid 44561636)
8. Kalantar-Zadeh K., Rodriguez R. A., Humphreys M. H., Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrology Dialysis Transplantation 2004 19 1 141 149 2-s2.0-0346656654 10.1093/ndt/gfg493 (Pubitemid 38072625)
9. Beerenhout C., Bekers O., Kooman J. P., van der Sande F. M., Leunissen K. M. L., A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients. Nephron 2002 92 1 32 35 2-s2.0-0036375428 10.1159/000064468 (Pubitemid 34983872)
10. Skikne B. S., Serum transferrin receptor. The American Journal of Hematology 2008 83 11 872 875 2-s2.0-55549127206 10.1002/ajh.21279
11. Weiss G., Iron metabolism in the anemia of chronic disease. Biochimica et Biophysica Acta 2009 1790 7 682 693 2-s2.0-67349115201 10.1016/j.bbagen.2008. 08.006
12. Lankhorst C. E., Wish J. B., Anemia in renal disease: diagnosis and management. Blood Reviews 2010 24 1 39 47 2-s2.0-71649083056 10.1016/j.blre.2009.09.001
13. Cavill I., Macdougall I. C., Functional iron deficiency. Blood 1993 82 4, article 1377 2-s2.0-0027301307
14. Macdougall I. C., Poor response to erythropoietin: practical guidelines on investigation and management. Nephrology Dialysis Transplantation 1995 10 5 607 614 2-s2.0-0029038221
15. Zager R. A., Johnson A. C. M., Hanson S. Y., Wasse H., Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. The American Journal of Kidney Diseases 2002 40 1 90 103 2-s2.0-0036280354 10.1053/ajkd.2002.33917 (Pubitemid 34701216)
16. Wish J. B., Assessing iron status: beyond serum ferritin and transferrin saturation. Clinical Journal of the American Society of Nephrology 2006 1 S4 S8 2-s2.0-33846702712 10.2215/CJN.01490506
17. Katodritou E., Zervas K., Terpos E., Brugnara C., Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated. British Journal of Haematology 2008 142 1 3 10 2-s2.0-44649144778 10.1111/j.1365-2141.2008.07163.x (Pubitemid 351783159)
18. Locatelli F., Aljama P., Bárány P., Canaud B., Carrera F., Eckardt K. U., Hörl W. H., Macdougal I. C., Macleod A., Wiecek A., Cameron S., Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation 2004 19 supplement 2 ii1 ii47 2-s2.0-4344581912
19. Buttarello M., Plebani M., Automated blood cell counts: state of the art. The American Journal of Clinical Pathology 2008 130 1 104 116 2-s2.0-48249141136 10.1309/EK3C7CTDKNVPXVTN
20. Higgins J. M., Mahadevan L., Physiological and pathological population dynamics of circulating human red blood cells. Proceedings of the National Academy of Sciences of the United States of America 2010 107 20587 20592 10.1073/pnas.1012747107
21. Cullen P., Söffker J., Höpfl M., Bremer C., Schlaghecken R., Mahrens T., Assmann G., Schaefer R. M., Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrology Dialysis Transplantation 1999 14 3 659 665 2-s2.0-0344699450 (Pubitemid 29105995)
22. Thomas C., Thomas L., Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clinical Chemistry 2002 48 7 1066 1076 2-s2.0-0036092825 (Pubitemid 34680903)
23. Mast A. E., Blinder M. A., Lu Q., Flax S., Dietzen D. J., Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002 99 4 1489 1491 2-s2.0-0037082503 10.1182/blood.V99.4.1489 (Pubitemid 34547111)
24. Brugnara C., Iron deficiency and erythropoiesis: new diagnostic approaches. Clinical Chemistry 2003 49 10 1573 1578 2-s2.0-0141504266 10.1373/49.10.1573 (Pubitemid 37194211)
25. Macdougall I. C., Merits of percentage hypochromic red cells as a marker of functional iron deficiency. Nephrology Dialysis Transplantation 1998 13 4 847 849 2-s2.0-0032041971 10.1093/ndt/13.4.847 (Pubitemid 28161751)
26. Bovy C., Gothot A., Krzesinski J. M., Beguin Y., Mature erythrocyte indices: new markers of iron availability. Haematologica 2005 90 4 549 551 2-s2.0-17844373006 (Pubitemid 40592899)
27. Bovy C., Gothot A., Delanaye P., Warling X., Krzesinski J. M., Beguin Y., Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation 2007 22 4 1156 1162 2-s2.0-34047180595 10.1093/ndt/gfl765 (Pubitemid 46523432)
28. Kotisaari S., Romppanen J., Penttilä I., Punnonen K., The Advia 120 red blood cell and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. European Journal of Haematology 2002 68 3 150 156 2-s2.0-0036269946 10.1034/j.1600-0609.2002.01532.x (Pubitemid 34620603)
29. National kidney foundation, kidney disease outcomes quality initiative NKF-K/DOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease. The American Journal of Kidney Disease 2006 47 5, supplement 3 S11 S145
30. Locatelli F., Covic A., Eckardt K. U., Wiecek A., Vanholder R., Anaemia management in patients with chronic kidney disease: a position statement by the anaemia working group of European renal best practice (ERBP). Nephrology Dialysis Transplantation 2009 24 2 348 354 2-s2.0-58649094413 10.1093/ndt/gfn653
31. Goodnough L. T., Nemeth E., Ganz T., Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010 116 23 4754 4761 2-s2.0-78649753411 10.1182/blood-2010-05-286260
32. Ervasti M., Kotisaari S., Heinonen S., Punnonen K., Use of advanced red blood cell and reticulocyte indices improves the accuracy in diagnosing iron deficiency in pregnant women at term. European Journal of Haematology 2007 79 6 539 545 2-s2.0-36249019867 10.1111/j.1600-0609.2007.00964.x (Pubitemid 350126672)
33. Ervasti M., Kotisaari S., Sankilampi U., Heinonen S., Punnonen K., The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns. Clinical Chemistry and Laboratory Medicine 2007 45 8 1000 1003 2-s2.0-34548744086 10.1515/CCLM.2007.187 (Pubitemid 47424852)
34. Suominen P., Punnonen K., Rajamäki A., Irjala K., Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998 92 8 2934 2939 2-s2.0-0032532635 (Pubitemid 28469109)
35. Stoffman N., Brugnara C., Woods E. R., An algorithm using reticulocyte hemoglobin content (CHr) measurement in screening adolescents for iron deficiency. Journal of Adolescent Health 2005 36 6 529 533 2-s2.0-19344365817 10.1016/j.jadohealth.2004.09.011 (Pubitemid 40719902)
36. Ullrich C., Wu A., Armsby C., Rieber S., Wingerter S., Brugnara C., Shapiro D., Bernstein H., Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. The Journal of the American Medical Association 2005 294 8 924 930 2-s2.0-23944517802 10.1001/jama.294.8.924 (Pubitemid 41215461)
37. Shaker M., Jenkins P., Ullrich C., Brugnara C., Nghiem B. T., Bernstein H., An economic analysis of anemia prevention during infancy. Journal of Pediatrics 2009 154 1 44 49 2-s2.0-57249095881 10.1016/j.jpeds.2008.06.038
38. Ramakers C., van der Woude D. A. A., Verzijl J. M., Pijnenborg J. M. A., van Wijk E. M., An added value for CHr and MCV in the diagnosis of iron deficency in postpartum anemic women. International Journal of Laboratory Hematology 2012 34 5 510 516 10.1111/j.1751-553X.2012.01423.x
39. Radtke H., Meyer T., Kalus U., Röcker L., Salama A., Kiesewetter H., Latza R., Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion 2005 45 1 5 10 2-s2.0-12544260050 10.1111/j.1537-2995.2005.04205.x
40. Nadarajan V., Sthaneshwar P., Eow G. I., Use of red blood cell indices for the identification of iron deficiency among blood donors. Transfusion Medicine 2008 18 3 184 189 2-s2.0-45349093255 10.1111/j.1365-3148.2008.00862.x (Pubitemid 351847335)
41. Semmelrock M. J., Raggam R. B., Amrein K., Avian A., Schallmoser K., Lanzer C., Semmelrock H. J., Prueller F., Berghold A., Rohde E., Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clinica Chimica Acta 2012 413 7-8 678 682 10.1016/j.cca.2011.12.006
42. Kang S. H., Kim H. K., Ham C. K., Lee D. S., Cho H. I., Comparison of four hematology analyzers, CELL-DYN Sapphire, ADVIA 120, Coulter LH 750, and Sysmex XE-2100, in terms of clinical usefulness. International Journal of Laboratory Hematology 2008 30 6 480 486 2-s2.0-55149091790 10.1111/j.1751-553X. 2007.00981.x
43. Ermens A. A. M., Hoffmann J. J. M. L., Krockenberger M., van Wijk E. M., New erythrocyte and reticulocyte parameters on CELL-DYN Sapphire; analytical and preanalytical aspects. International Journal of Laboratory Hematology 2012 34 3 274 282 10.1111/j.1751-553X.2011.01391.x
44. Hoffmann J. J. M. L., van den Broek N. M. A., Curvers J., Reference intervals of extended erythrocyte and reticulocyte parameters. Clinical Chemistry and Laboratory Medicine 2012 50 5 941 948
45. Costa O., van Moer G., Jochmans K., Jonckheer J., Damiaens S., de Waele M., Reference values for new red blood cell and platelet parameters on the Abbott Diagnostics Cell-Dyn Sapphire. Clinical Chemistry and Laboratory Medicine 2012 50 5 967 969
46. Buttarello M., Temporin V., Ceravolo R., Farina G., Bulian P., The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia. The American Journal of Clinical Pathology 2004 121 4 489 495 2-s2.0-1642299543 10.1309/W652-95DT-UWK7- U1HH (Pubitemid 38392956)
47. Canals C., Remacha A. F., Sardá M. P., Piazuelo J. M., Royo M. T., Angeles Romero M., Clinical utility of the new Sysmex XE 2100 parameter-reticulocyte hemoglobin equivalent-in the diagnosis of anemia. Haematologica 2005 90 8 1133 1134 2-s2.0-24944584679 (Pubitemid 41323514)
48. Brugnara C., Schiller B., Moran J., Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clinical and Laboratory Haematology 2006 28 5 303 308 2-s2.0-33748997056 10.1111/j.1365-2257.2006.00812. x (Pubitemid 44453675)
49. Thomas C., Kirschbaum A., Boehm D., Thomas L., The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Medical Oncology 2006 23 1 23 36 2-s2.0-33646861415 10.1385/MO:23:1:23 (Pubitemid 43787115)
50. Thomas L., Franck S., Messinger M., Linssen J., Thomé M., Thomas C., Reticulocyte hemoglobin measurement-comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clinical Chemistry and Laboratory Medicine 2005 43 11 1193 1202 2-s2.0-27744441117 10.1515/CCLM.2005.207 (Pubitemid 41600670)
51. David O., Grillo A., Ceoloni B., Cavallo F., Podda G., Biancotti P. P., Bergamo D., Canavese C., Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease. Scandinavian Journal of Clinical and Laboratory Investigation 2006 66 2 113 120 2-s2.0-33644997243 10.1080/00365510500406910
52. Garzia M., Di Mario A., Ferraro E., Tazza L., Rossi E., Luciani G., Zini G., Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. Laboratory Hematology 2007 13 1 6 11 2-s2.0-34147195735 10.1532/LH96.06037 (Pubitemid 46578456)
53. Mast A. E., Blinder M. A., Dietzen D. J., Reticulocyte hemoglobin content. The American Journal of Hematology 2008 83 4 307 310 2-s2.0-41449106883 10.1002/ajh.21090 (Pubitemid 351458009)
54. MacOni M., Cavalca L., Danise P., Cardarelli F., Brini M., Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. Scandinavian Journal of Clinical and Laboratory Investigation 2009 69 3 365 370 2-s2.0-67649752351 10.1080/00365510802657673
55. Miwa N., Akiba T., Kimata N., Hamaguchi Y., Arakawa Y., Tamura T., Nitta K., Tsuchiya K., Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency. International Journal of Laboratory Hematology 2010 32 2 248 255 2-s2.0-77953554528 10.1111/j.1751-553X.2009.01179.x
56. Préfontaine G., Darveau M., Ahnadi C., Lachance P., Lesur O., Drouin C., Lamarre P., Vézina C., Reticulocyte hemoglobin content in 13 critically ill patients: a preliminary study. Transfusion Alternatives in Transfusion Medicine 2008 10 4 182 188 2-s2.0-64349097791 10.1111/j.1778-428X. 2009.00123.x
57. Fernández R., Tubau I., Masip J., Muñoz L., Roig I., Artigas A., Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology 2010 112 5 1211 1215 2-s2.0-77951678929 10.1097/ALN.0b013e3181d74f87
58. Schoorl M., Snijders D., Schoorl M., Boersma W. G., Bartels P. C. M., Temporary impairment of reticulocyte hemoglobin content in subjects with community adquired pneumonia. International Journal of Laboratory Hematology 2012 34 4 390 395 10.1111/j.1751-553X.2012.01408.x
59. Urrechaga E., Borque L., Escanero J. F., Potential utility of the new sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clinical Chemistry and Laboratory Medicine 2009 47 11 1411 1416 2-s2.0-73349110102 10.1515/CCLM.2009.301
60. Urrechaga E., Borque L., Escanero J. F., Percentage of hypochromic erythrocytes as potential marker of iron availability. Clinical Chemistry and Laboratory Medicine 2012 50 4 685 687
61. Urrechaga E., Borque L., Escanero J. F., Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability. International Journal of Laboratory Hematology 10.1111/ijlh.12013
62. Buttarello M., Pajola R., Novello E., Rebeschini M., Cantaro S., Oliosi F., Naso A., Plebani M., Diagnosis of iron deficiency in patients undergoing hemodialysis. The American Journal of Clinical Pathology 2010 133 6 949 954 2-s2.0-77952989605 10.1309/AJCPQAX0JFHFS0OA
63. Urrechaga E., The new mature red cell parameter, low haemoglobin density of the Beckman-Coulter LH750: clinical utility in the diagnosis of iron deficiency. International Journal of Laboratory Hematology 2010 32 1 e144 e150 2-s2.0-77249172320 10.1111/j.1751-553X.2008.01127.x
64. Urrechaga E., Borque L., Escanero J. F., Erythrocyte and reticulocyte indices on the LH 750 as potential markers of functional iron deficiency. Anemia 2010 2010 7 625919 10.1155/2010/625919
65. Urrechaga E., Borque L., Escanero J. F., Low Hemoglobin Density (LHD %) potential marker of iron availability. International Journal of Laboratory Hematology 2012 34 1 47 51 10.1111/j.1751-553X.2011.01355.x
66. Urrechaga E., Borque L., Escanero J. F., Gööz M., Assessing iron status in CKD patients: new Laboratory parameters. Chronic Kidney Disease 2012 1st Zagreb, Croatia InTech 225 250
67. Ptolemy A. S., Rifai N., What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scandinavian Journal of Clinical and Laboratory Investigation 2010 70 s242 6 14 2-s2.0-77953148386 10.3109/00365513.2010.493354